NCT05095532View on ClinicalTrials.gov

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

PHASE1RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Chronic PancreatitisMesenchymal Stem Cells
Interventions
BIOLOGICAL

Bone marrow-derived mesenchymal stem cells

MSC transplantation

OTHER

Placebo

Standard of Care

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Medical University of South Carolina

OTHER